tiprankstipranks
Advertisement
Advertisement

HK:2496 Stock Latest News

Wuhan YZY Biopharma Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate
Company AnnouncementsWuhan YZY Biopharma Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate
10d ago
2496
YZY Biopharma’s M701 Shows Promising Phase III Data Ahead of 2026 ASCO
PremiumCompany Announcements
YZY Biopharma’s M701 Shows Promising Phase III Data Ahead of 2026 ASCO
27d ago
2496
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative
PremiumCompany Announcements
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative
1M ago
2496
YZY Biopharma’s Lead Cancer Bispecific M701 Wins NMPA NDA Acceptance
PremiumCompany Announcements
YZY Biopharma’s Lead Cancer Bispecific M701 Wins NMPA NDA Acceptance
1M ago
2496
YZY Biopharma’s M701 Data Secured for High-Profile ASCO 2026 Presentations
PremiumCompany Announcements
YZY Biopharma’s M701 Data Secured for High-Profile ASCO 2026 Presentations
2M ago
2496
Wuhan YZY Biopharma Completes Full Circulation of H Shares to Boost Market Liquidity
PremiumCompany AnnouncementsWuhan YZY Biopharma Completes Full Circulation of H Shares to Boost Market Liquidity
3M ago
2496
Wuhan YZY Biopharma Swings to Net Liabilities as 2025 Revenue Falls
Premium
Company Announcements
Wuhan YZY Biopharma Swings to Net Liabilities as 2025 Revenue Falls
3M ago
2496
Wuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results
Premium
Company Announcements
Wuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results
3M ago
2496
Wuhan YZY Biopharma Confirms Land and Building Transfer Will Not Affect R&D or Commercial Plans
PremiumCompany Announcements
Wuhan YZY Biopharma Confirms Land and Building Transfer Will Not Affect R&D or Commercial Plans
4M ago
2496
Wuhan YZY Biopharma Wins HKEX Approval for Full H-Share Circulation of 35% Stake
PremiumCompany Announcements
Wuhan YZY Biopharma Wins HKEX Approval for Full H-Share Circulation of 35% Stake
4M ago
2496
Wuhan YZY Biopharma Wins FDA IND Approval for Bispecific Antibody M701 in Malignant Pleural Effusion
PremiumCompany Announcements
Wuhan YZY Biopharma Wins FDA IND Approval for Bispecific Antibody M701 in Malignant Pleural Effusion
4M ago
2496
Wuhan YZY Biopharma Clears CSRC Filing for H Share Full Circulation Plan
PremiumCompany Announcements
Wuhan YZY Biopharma Clears CSRC Filing for H Share Full Circulation Plan
5M ago
2496
Wuhan YZY Biopharma to Transfer Wuhan Industrial Land and Building for RMB36.88 Million
PremiumCompany AnnouncementsWuhan YZY Biopharma to Transfer Wuhan Industrial Land and Building for RMB36.88 Million
5M ago
2496
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative Supervisor
Premium
Company Announcements
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative Supervisor
6M ago
2496
Wuhan YZY Biopharma Wins NMPA IND Nod for Hemlibra Biosimilar Y225 and Deepens Antibody R&D Push
Premium
Company Announcements
Wuhan YZY Biopharma Wins NMPA IND Nod for Hemlibra Biosimilar Y225 and Deepens Antibody R&D Push
6M ago
2496
Wuhan YZY Biopharma’s M701 Shows Promising Results in Phase II Trial
PremiumCompany Announcements
Wuhan YZY Biopharma’s M701 Shows Promising Results in Phase II Trial
7M ago
2496
Wuhan YZY Biopharma Reports Promising Phase II Results for M701 in Treating Malignant Pleural Effusion
PremiumCompany Announcements
Wuhan YZY Biopharma Reports Promising Phase II Results for M701 in Treating Malignant Pleural Effusion
8M ago
2496
Wuhan YZY Biopharma Announces Change in Supervisory Committee
PremiumCompany Announcements
Wuhan YZY Biopharma Announces Change in Supervisory Committee
9M ago
2496
Wuhan YZY Biopharma Reports Interim 2025 Financial Results Amid R&D Focus
PremiumCompany Announcements
Wuhan YZY Biopharma Reports Interim 2025 Financial Results Amid R&D Focus
10M ago
2496
Wuhan YZY Biopharma Schedules Board Meeting to Review Interim Results
PremiumCompany AnnouncementsWuhan YZY Biopharma Schedules Board Meeting to Review Interim Results
10M ago
2496
Wuhan YZY Biopharma Announces AGM Results and Board Elections
Premium
Company Announcements
Wuhan YZY Biopharma Announces AGM Results and Board Elections
12M ago
2496
Wuhan YZY Biopharma Announces Board Composition and Roles
Premium
Company Announcements
Wuhan YZY Biopharma Announces Board Composition and Roles
12M ago
2496

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >